This research project studies the influence of biomechanical stress on the development, progression and rupture of atherosclerotic plaques.
We aim to unravel the etiology of cardiovascular complications in patients with congenital heart disease and to advance personalized treatment of these patients.
Targeted microbubble vibrations to accurately diagnose and treat cardiac device-related bacterial biofilm infections (ERC starting grant Kooiman)
Drug delivery through microbubbles: the quest for the missing link (VIDI Kooiman)
This multidisciplinary project is performed by a team of engineers and clinicians from the Departments of Biomedical Engineering, Cardiology, Pediatric Cardiology and Radiology.
EFFECTS delivers a technique for early diagnosis of heart failure by measuring the stiffening of the heart, through non-invasive ultrasound imaging.
We tissue engineer human disease models for atherosclerosis to unravel the process of atherosclerotic plaque rupture and to identify new imaging biomarkers.
(Vici Van Soest)
We develop new diagnostic imaging, aimed at targeting inflammation and calcification with radionuclide imaging, to assess atherosclerotic plaque composition.
Photoacoustic imaging of Radiofrequency Ablation for Atrial Fibrillation Part of the NWO Perspectief consortium iMIT
This project focusses on new echography to measure the blood flow inside the heart wall, such that the interventions in the Cath lab can be better monitored.
This project is part of the Medical Delta and primarily is a collaboration between the MISIT group of the 3mE faculty at TU Delft, Surgery at LUMC, and the BME group of the Thorax Center at Erasmus MC.
I aim to develop new imaging technologies to visualize vulnerable plaques and other disease at early stage.
This project is using ultrasound and microbubbles for sonobactericde (Erasmus MC fellowship Kooiman)
This project is developing novel phospolipid-coated microbubbles, i.e. ultrasound contrast agents, for ultrasound molecular imaging and drug delivery.
